USPTO serial 79352396
BIBRIDGED
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 30, 2024
- Examiner
- LEE, JANET H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIBRIDGED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Tara Reedy Sliva
Tara Reedy Sliva Dentons US LLPP.O. Box 1302Chicago, IL 60604United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Synthetic peptides for pharmaceutical purposes, namely for the treatment of cancer, inflammatory diseases, skin disorders, eye disorders; Peptides for pharmaceutical purposes, namely for the treatment of cancer, inflammatory diseases, skin disorders, eye disorders; peptides for medical diagnostical purposes; peptides for diagnostical purposes in medical fields; peptides for serological purposes for the treatment of cancer, inflammatory diseases, skin disorders, eye disorders; peptides for radioimaging purposes in medical fields, namely diagnostic kits consisting primarily of monoclonal antibodies or mimics thereof consisting of peptides, buffers, and reagents for use in disease testing; peptides for use in the field of oncology for the treatment of cancer; pharmaceutical preparations based on peptides for the treatment of cancer, inflammatory diseases, skin disorders, eye disorders; peptide mimics of antibodies for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 30, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 9, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 11, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 23, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 22, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 22, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 27, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 27, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 25, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 18, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 14, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 13, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |